Morgan Stanley and Perella Weinberg Partners Capital Management LP Launch UCITS Fund
Fund launched on Morgan Stanley’s FundLogic Alternatives Plc
Morgan Stanley (NYSE: MS) today announced the launch of a new fund under its UCITS Irish Umbrella, FundLogic Alternatives Plc. The MS Perella Weinberg Partners Tōkum Long/Short Healthcare UCITS Fund will be managed by Perella Weinberg Partners, an independent financial services firm with approximately US$8.2 billion of assets under management.
The new fund will offer access to a global long/short equity strategy focused on the healthcare industry (including biotechnologies, pharmaceuticals and companies engaged in the medical technology and services businesses) and will seek attractive risk-adjusted returns.
David Armstrong, Managing Director and Global Head of the Fund and Fund-Linked business at Morgan Stanley commented: “In less than a year of running our FundLogic Alternatives Platform, we have successfully put to market a wide range of alternative strategies in a UCITS format, with programs covering long/short equity, event-driven and convertible arbitrage. The launch of the MS Perella Weinberg Partners Tōkum Long/Short Healthcare UCITS Fund adds an outstanding option to gain exposure to a new sector focused strategy. We look forward to our partnership with Perella Weinberg Partners to offer investors a new route to capture the evolutions of the healthcare industry.”
Greth Lester, responsible for overseeing Perella Weinberg Partners’ investor relations and asset management business in Europe, commented: “We are delighted to collaborate with Morgan Stanley, one of the leading providers of alternative strategies in a UCITS format, for the launch of the MS Perella Weinberg Partners Tōkum Long/Short Healthcare UCITS Fund. Morgan Stanley has an impressive track-record of successfully launching alternative UCITS strategies, which we believe will further enhance our European presence and provide new opportunities to investors in search of an attractive absolute return profile focusing on long/short healthcare opportunities.”
Emile Westergaard, Portfolio Manager of the MS Perella Weinberg Partners Tōkum Long/Short Healthcare UCITS Fund, added: “The MS Perella Weinberg Partners Tōkum Long/Short Healthcare UCITS Fund will leverage our team’s bottom-up fundamental research process to identify, within the healthcare industry’s rapidly evolving technological and regulatory frameworks, material levers impacting businesses positively or negatively over a two to four-year horizon. We strongly believe our unique portfolio construction matrix, which has been developed to take into account a multi-factored set of inputs guided by absolute return objectives, implied volatility targets and liquidity requirements, fits well within the UCITS framework.”
FundLogic is the platform brand name for Morgan Stanley fund solutions launched in 2006.
It can offer both UCITS and non-UCITS Funds on a global basis. The platform delivers fund solutions to clients by combining the financial expertise, innovation and resources of Morgan Stanley and offers a range of products including simple Index Funds, Structured Funds and the more recently launched Third Party managers UCITS Funds.
For further information, please email us at email@example.com
Fund Name: MS Perella Weinberg Partners Tōkum Long/Short Healthcare UCITS Fund
Umbrella Fund: FundLogic Alternatives Plc
Funds domicile: Ireland
Investment Manager: Perella Weinberg Partners Capital Management LP
Promoter: Morgan Stanley & Co International Plc
Custodian: Northern Trust Fiduciary Services (Ireland) Limited
Administrator: Northern Trust International Fund Administration Services (Ireland) Ltd
Morgan Stanley is a leading global financial services firm providing a wide range of investment banking, securities, investment management and wealth management services. The Firm's employees serve clients worldwide including corporations, governments, institutions and individuals from more than 1,300 offices in 42 countries. For further information about Morgan Stanley, please visit www.morganstanley.com.
Applications for shares in any sub-fund of the FundLogic Alternatives plc (the “Fund”) should not be made without first consulting the Fund’s current Prospectus, Simplified Prospectus, Annual Report and Semi-Annual Report (“Offering Documents”), or other documents available in your local jurisdiction which are available free of charge from Morgan Stanley & Co International plc.
THE SECURITIES MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS AT ANY TIME (AS DEFINED IN REGULATION S UNDER THE U.S. SECURITIES ACT OF 1933 OR THE U.S. INTERNAL REVENUE CODE). The Securities have not been and will not be registered under the U.S. Securities Act of 1933, as amended, or the securities laws of any State in the United States, and may be subject to U.S. tax requirements. The Securities may not be offered, sold, transferred or delivered without compliance with all applicable securities laws and regulations.
Media Relations Contact: Sebastian Howell, +44.20.7425.5324